129 related articles for article (PubMed ID: 38788713)
1. Meningioma transcriptomic landscape demonstrates novel subtypes with regional associated biology and patient outcome.
Thirimanne HN; Almiron-Bonnin D; Nuechterlein N; Arora S; Jensen M; Parada CA; Qiu C; Szulzewsky F; English CW; Chen WC; Sievers P; Nassiri F; Wang JZ; Klisch TJ; Aldape KD; Patel AJ; Cimino PJ; Zadeh G; Sahm F; Raleigh DR; Shendure J; Ferreira M; Holland EC
Cell Genom; 2024 Jun; 4(6):100566. PubMed ID: 38788713
[TBL] [Abstract][Full Text] [Related]
2. DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis.
Sahm F; Schrimpf D; Stichel D; Jones DTW; Hielscher T; Schefzyk S; Okonechnikov K; Koelsche C; Reuss DE; Capper D; Sturm D; Wirsching HG; Berghoff AS; Baumgarten P; Kratz A; Huang K; Wefers AK; Hovestadt V; Sill M; Ellis HP; Kurian KM; Okuducu AF; Jungk C; Drueschler K; Schick M; Bewerunge-Hudler M; Mawrin C; Seiz-Rosenhagen M; Ketter R; Simon M; Westphal M; Lamszus K; Becker A; Koch A; Schittenhelm J; Rushing EJ; Collins VP; Brehmer S; Chavez L; Platten M; Hänggi D; Unterberg A; Paulus W; Wick W; Pfister SM; Mittelbronn M; Preusser M; Herold-Mende C; Weller M; von Deimling A
Lancet Oncol; 2017 May; 18(5):682-694. PubMed ID: 28314689
[TBL] [Abstract][Full Text] [Related]
3. DNA methylation profiling demonstrates superior diagnostic classification to RNA-sequencing in a case of metastatic meningioma.
Vasudevan HN; Castro MRH; Lee JC; Villanueva-Meyer JE; Bush NAO; McDermott MW; Solomon DA; Perry A; Magill ST; Raleigh DR
Acta Neuropathol Commun; 2020 Jun; 8(1):82. PubMed ID: 32517746
[TBL] [Abstract][Full Text] [Related]
4. Leveraging single-cell sequencing to classify and characterize tumor subgroups in bulk RNA-sequencing data.
Shetty A; Wang S; Khan AB; English CW; Nouri SH; Magill ST; Raleigh DR; Klisch TJ; Harmanci AO; Patel AJ; Harmanci AS
J Neurooncol; 2024 Jul; 168(3):515-524. PubMed ID: 38811523
[TBL] [Abstract][Full Text] [Related]
5. An integrated genomic analysis of anaplastic meningioma identifies prognostic molecular signatures.
Collord G; Tarpey P; Kurbatova N; Martincorena I; Moran S; Castro M; Nagy T; Bignell G; Maura F; Young MD; Berna J; Tubio JMC; McMurran CE; Young AMH; Sanders M; Noorani I; Price SJ; Watts C; Leipnitz E; Kirsch M; Schackert G; Pearson D; Devadass A; Ram Z; Collins VP; Allinson K; Jenkinson MD; Zakaria R; Syed K; Hanemann CO; Dunn J; McDermott MW; Kirollos RW; Vassiliou GS; Esteller M; Behjati S; Brazma A; Santarius T; McDermott U
Sci Rep; 2018 Sep; 8(1):13537. PubMed ID: 30202034
[TBL] [Abstract][Full Text] [Related]
6. Transcriptome signatures associated with meningioma progression.
Viaene AN; Zhang B; Martinez-Lage M; Xiang C; Tosi U; Thawani JP; Gungor B; Zhu Y; Roccograndi L; Zhang L; Bailey RL; Storm PB; O'Rourke DM; Resnick AC; Grady MS; Dahmane N
Acta Neuropathol Commun; 2019 Apr; 7(1):67. PubMed ID: 31039818
[TBL] [Abstract][Full Text] [Related]
7. Transcriptomic Profiling Revealed Lnc-GOLGA6A-1 as a Novel Prognostic Biomarker of Meningioma Recurrence.
Slavik H; Balik V; Kokas FZ; Slavkovsky R; Vrbkova J; Rehulkova A; Lausova T; Ehrmann J; Gurska S; Uberall I; Hajduch M; Srovnal J
Neurosurgery; 2022 Aug; 91(2):360-369. PubMed ID: 35551164
[TBL] [Abstract][Full Text] [Related]
8. Genetic alterations associated with progression and recurrence in meningiomas.
Pérez-Magán E; Campos-Martín Y; Mur P; Fiaño C; Ribalta T; García JF; Rey JA; Rodríguez de Lope A; Mollejo M; Meléndez B
J Neuropathol Exp Neurol; 2012 Oct; 71(10):882-93. PubMed ID: 22964784
[TBL] [Abstract][Full Text] [Related]
9. Microarray gene expression profiling in meningiomas: differential expression according to grade or histopathological subtype.
Fèvre-Montange M; Champier J; Durand A; Wierinckx A; Honnorat J; Guyotat J; Jouvet A
Int J Oncol; 2009 Dec; 35(6):1395-407. PubMed ID: 19885562
[TBL] [Abstract][Full Text] [Related]
10. Gene expression profiles of metabolic aggressiveness and tumor recurrence in benign meningioma.
Serna E; Morales JM; Mata M; Gonzalez-Darder J; San Miguel T; Gil-Benso R; Lopez-Gines C; Cerda-Nicolas M; Monleon D
PLoS One; 2013; 8(6):e67291. PubMed ID: 23840654
[TBL] [Abstract][Full Text] [Related]
11. Transcriptomic analysis of aggressive meningiomas identifies PTTG1 and LEPR as prognostic biomarkers independent of WHO grade.
Schmidt M; Mock A; Jungk C; Sahm F; Ull AT; Warta R; Lamszus K; Gousias K; Ketter R; Roesch S; Rapp C; Schefzyk S; Urbschat S; Lahrmann B; Kessler AF; Löhr M; Senft C; Grabe N; Reuss D; Beckhove P; Westphal M; von Deimling A; Unterberg A; Simon M; Herold-Mende C
Oncotarget; 2016 Mar; 7(12):14551-68. PubMed ID: 26894859
[TBL] [Abstract][Full Text] [Related]
12. Identification of Meningioma Patients at High Risk of Tumor Recurrence Using MicroRNA Profiling.
Slavik H; Balik V; Vrbkova J; Rehulkova A; Vaverka M; Hrabalek L; Ehrmann J; Vidlarova M; Gurska S; Hajduch M; Srovnal J
Neurosurgery; 2020 Oct; 87(5):1055-1063. PubMed ID: 32125436
[TBL] [Abstract][Full Text] [Related]
13. RNA-seq transcriptome analysis of formalin fixed, paraffin-embedded canine meningioma.
Grenier JK; Foureman PA; Sloma EA; Miller AD
PLoS One; 2017; 12(10):e0187150. PubMed ID: 29073243
[TBL] [Abstract][Full Text] [Related]
14. Meningioma: current updates on genetics, classification, and mouse modeling.
Szulzewsky F; Thirimanne HN; Holland EC
Ups J Med Sci; 2024; 129():. PubMed ID: 38571886
[TBL] [Abstract][Full Text] [Related]
15. Cathepsins B and L and their inhibitors stefin B and cystatin C as markers for malignant progression of benign meningiomas.
Trinkaus M; Vranic A; Dolenc VV; Lah TT
Int J Biol Markers; 2005; 20(1):50-9. PubMed ID: 15832773
[TBL] [Abstract][Full Text] [Related]
16. First insight into the somatic mutation burden of neurofibromatosis type 2-associated grade I and grade II meningiomas: a case report comprehensive genomic study of two cranial meningiomas with vastly different clinical presentation.
Dewan R; Pemov A; Dutra AS; Pak ED; Edwards NA; Ray-Chaudhury A; Hansen NF; Chandrasekharappa SC; Mullikin JC; Asthagiri AR; ; Heiss JD; Stewart DR; Germanwala AV
BMC Cancer; 2017 Feb; 17(1):127. PubMed ID: 28193203
[TBL] [Abstract][Full Text] [Related]
17. Genomic landscape of meningiomas.
Lee Y; Liu J; Patel S; Cloughesy T; Lai A; Farooqi H; Seligson D; Dong J; Liau L; Becker D; Mischel P; Shams S; Nelson S
Brain Pathol; 2010 Jul; 20(4):751-62. PubMed ID: 20015288
[TBL] [Abstract][Full Text] [Related]
18. Mutational patterns and regulatory networks in epigenetic subgroups of meningioma.
Paramasivam N; Hübschmann D; Toprak UH; Ishaque N; Neidert M; Schrimpf D; Stichel D; Reuss D; Sievers P; Reinhardt A; Wefers AK; Jones DTW; Gu Z; Werner J; Uhrig S; Wirsching HG; Schick M; Bewerunge-Hudler M; Beck K; Brehmer S; Urbschat S; Seiz-Rosenhagen M; Hänggi D; Herold-Mende C; Ketter R; Eils R; Ram Z; Pfister SM; Wick W; Weller M; Grossmann R; von Deimling A; Schlesner M; Sahm F
Acta Neuropathol; 2019 Aug; 138(2):295-308. PubMed ID: 31069492
[TBL] [Abstract][Full Text] [Related]
19. A microRNA expression signature predicts meningioma recurrence.
Zhi F; Zhou G; Wang S; Shi Y; Peng Y; Shao N; Guan W; Qu H; Zhang Y; Wang Q; Yang C; Wang R; Wu S; Xia X; Yang Y
Int J Cancer; 2013 Jan; 132(1):128-36. PubMed ID: 22674195
[TBL] [Abstract][Full Text] [Related]
20. Single-cell RNA sequencing identifies macrophage signatures correlated with clinical features and tumour microenvironment in meningiomas.
Zhang X
IET Syst Biol; 2023 Oct; 17(5):259-270. PubMed ID: 37515398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
